Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ RelA/NFkB p65 Antibody Blocking Peptide
SDP

Catalog No. NB398703 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NB398703 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NB398703 Supplier Novus Biologicals™ Supplier No. NB10056502PEP
Only null left
Add to Cart
Add to Cart

Specifications

Gene ID (Entrez) 5970
Concentration 1 mg/mL
Content And Storage Store at -80°C. Avoid freeze/thaw cycles.
For Use With (Application) This Peptide is Useful as a Blocking Peptide for NB100-56502
Gene Alias MGC131774, nf kb p65, NFkB p65, NF-kB p65, NFKB3v-rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor ofkappa light polypeptide gene enhancer in B-cells 3 (p65)), Nuclear factor NF-kappa-B p65 subunit, Nuclear factor of kappa light polypeptide gene enhancer in B-cells 3 transcription factor p65, p65, RelA, rela p65, v-rel reticuloendotheliosis viral oncogene homolog A (avian), v-rel reticuloendotheliosis viral oncogene homolog A, nuclear factor of kappalight polypeptide gene enhancer in B-cells 3, p65
Gene Symbol RELA
Quantity 0.1 mg
Research Category Apoptosis, Cancer, Cell Biology, Immune System Diseases, Immunology, Innate Immunity, Neurodegeneration, Neuroscience, Phospho Specific, Signal Transduction, Transcription Factors and Regulators
Storage Buffer Peptide dissolved in dH20. Contains no BSA.
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.